Completed NA INTERVENTIONAL 2-arm NCT02955875

Pharmaceutical Care Service in Diabetes (IMPACT4-DM)

Impact of Pharmaceutical Care Service for Type 2 Diabetes Mellitus Patients in Korea

Sponsor: Pusan National University

Updated 5 times since 2017 Last updated: Nov 2, 2016 Started: Jan 31, 2015 Primary completion: May 31, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02955875, this NA trial focuses on Diabetes Mellitus, Type 2 and remains completed. Sponsored by Pusan National University, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pusan National University
Pusan National University Hospital

Data source: Pusan National University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.